[Antibody dependent cell-bound cytotoxicity in systemic lupus erythematosus]. 1978

I Láng, and B Fekete, and K Török, and K Pálóczi, and I Sonkoly, and G Szegedi, and P Gergely

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell

Related Publications

I Láng, and B Fekete, and K Török, and K Pálóczi, and I Sonkoly, and G Szegedi, and P Gergely
May 1975, Clinical and experimental immunology,
I Láng, and B Fekete, and K Török, and K Pálóczi, and I Sonkoly, and G Szegedi, and P Gergely
February 1981, Annals of the rheumatic diseases,
I Láng, and B Fekete, and K Török, and K Pálóczi, and I Sonkoly, and G Szegedi, and P Gergely
November 1978, Clinical and experimental immunology,
I Láng, and B Fekete, and K Török, and K Pálóczi, and I Sonkoly, and G Szegedi, and P Gergely
July 1985, Journal of clinical & laboratory immunology,
I Láng, and B Fekete, and K Török, and K Pálóczi, and I Sonkoly, and G Szegedi, and P Gergely
January 1982, The Journal of rheumatology,
I Láng, and B Fekete, and K Török, and K Pálóczi, and I Sonkoly, and G Szegedi, and P Gergely
November 1980, Arthritis and rheumatism,
I Láng, and B Fekete, and K Török, and K Pálóczi, and I Sonkoly, and G Szegedi, and P Gergely
March 1984, Journal of clinical & laboratory immunology,
I Láng, and B Fekete, and K Török, and K Pálóczi, and I Sonkoly, and G Szegedi, and P Gergely
August 1983, The Journal of rheumatology,
I Láng, and B Fekete, and K Török, and K Pálóczi, and I Sonkoly, and G Szegedi, and P Gergely
January 1984, Terapevticheskii arkhiv,
I Láng, and B Fekete, and K Török, and K Pálóczi, and I Sonkoly, and G Szegedi, and P Gergely
October 1992, British journal of rheumatology,
Copied contents to your clipboard!